← Leaderboards
Louis M. Weiss
Yeshiva University
$25,429,187
Attributed
$27,091,534
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,091,534 · 18
By mechanism
R01$20,898,708 · 7
T32$2,437,484 · 1
R21$1,854,748 · 4
P20$858,819 · 1
S10$598,754 · 1
R56$415,417 · 1
Top collaborators
- Bhaskar Chandra Das6 shared
- Ruth Hogue Angeletti3 shared
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionPathogenOrganismStructureAcquired Immunodeficiency SyndromeProteomicsOpportunistic InfectionsProteinsCellsImmuneLaboratoriesMammalsAnimalsFoodEncephalitisWaterTransmission ProcessGenesTherapeutic AgentsInvestigationUnited States National Institutes Of HealthMicrosporidiaToxoplasma GondiiBirds
Grant awards (75)
AIDS associated Toxoplasma encephalitis$2,456,732
R01 · FY2025 · AI · contact PI
Microsporidia: invasion apparatus$420,000
R01 · FY2025 · AI · contact PI
IVIS SpectrumCT$598,754
S10 · FY2024 · OD · contact PI
Microsporidia: invasion apparatus$420,000
R01 · FY2024 · AI · contact PI
Microsporidia: invasion apparatus$420,000
R01 · FY2023 · AI · contact PI
Geographic Medicine and Emerging Infections$359,919
T32 · FY2023 · AI · contact PI
Microsporidia: invasion apparatus$420,000
R01 · FY2022 · AI · contact PI
Composition and formation of the cyst wall$417,500
R01 · FY2022 · AI · contact PI
Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis$401,250
R01 · FY2022 · AI
Geographic Medicine and Emerging Infections$369,443
T32 · FY2022 · AI · contact PI
Microsporidia: invasion apparatus$420,000
R01 · FY2021 · AI · contact PI
Composition and formation of the cyst wall$417,500
R01 · FY2021 · AI · contact PI
Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis$401,250
R01 · FY2021 · AI
Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis$390,001
R01 · FY2021 · AI
Geographic Medicine and Emerging Infections$342,947
T32 · FY2021 · AI · contact PI
Composition and formation of the cyst wall$417,500
R01 · FY2020 · AI · contact PI
Microsporidia: invasion apparatus$417,500
R01 · FY2020 · AI · contact PI
Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis$414,750
R01 · FY2020 · AI
Geographic Medicine and Emerging Infections$324,631
T32 · FY2020 · AI · contact PI
Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis$420,625
R01 · FY2019 · AI
Composition and formation of the cyst wall$417,500
R01 · FY2019 · AI · contact PI
Microsporidia: invasion apparatus$417,500
R01 · FY2019 · AI · contact PI
Geographic Medicine and Emerging Infections$357,733
T32 · FY2019 · AI · contact PI
Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis$438,000
R01 · FY2018 · AI
Microsporidia: invasion apparatus$286,571
R01 · FY2018 · AI · contact PI
Composition and formation of the cyst wall$228,531
R01 · FY2018 · AI · contact PI
Toxoplasma gondii Glycosylation$215,125
R21 · FY2018 · AI · contact PI
Geographic Medicine and Emerging Infections$189,856
T32 · FY2018 · AI · contact PI
Composition and formation of the cyst wall$188,969
R01 · FY2018 · AI · contact PI
Geographic Medicine and Emerging Infections$144,856
T32 · FY2018 · AI · contact PI
Microsporidia: invasion apparatus$130,929
R01 · FY2018 · AI · contact PI
Microsporidia: invasion apparatus$417,500
R01 · FY2017 · AI · contact PI
Geographic Medicine and Emerging Infections$348,099
T32 · FY2017 · AI · contact PI
Toxoplasma gondii Glycosylation$273,625
R21 · FY2017 · AI · contact PI
Microsporidia: invasion apparatus$417,500
R01 · FY2016 · AI · contact PI
Toxoplasma gondii: cyst wall$417,500
R01 · FY2016 · AI · contact PI
Toxoplasma gondii: cyst wall$393,356
R01 · FY2015 · AI · contact PI
Toxoplasma gondii: cyst wall$24,144
R01 · FY2015 · AI · contact PI
Toxoplasma gondii: cyst wall$417,500
R01 · FY2014 · AI · contact PI
Toxoplasma gondii: cyst wall$392,450
R01 · FY2013 · AI · contact PI
Toxoplasma gondii: cyst wall$415,833
R01 · FY2012 · AI · contact PI
Microsporidia: Genetic Techniques$207,500
R21 · FY2012 · AI · contact PI
International Workshop on Opportunistic Protists (IWOP-12, 13 and 14)$5,604
R13 · FY2012 · AI · contact PI
Microsporidiosis: Rational Therapeutics$415,417
R56 · FY2011 · AI · contact PI
New Opportunistic Infections in AIDS Microsporidiosis$390,588
R01 · FY2011 · AI · contact PI
Proteomics Core$286,745
P20 · FY2011 · DA
Microsporidia: Genetic Techniques$249,000
R21 · FY2011 · AI · contact PI
New Opportunistic Infections in AIDS Microsporidiosis$394,737
R01 · FY2010 · AI · contact PI
Proteomics Core$299,270
P20 · FY2010 · DA
New Opportunistic Infections in AIDS Microsporidiosis$398,924
R01 · FY2009 · AI · contact PI
Toxoplasma encephalitis in AIDS: Bradyzoite Regulation$347,418
R01 · FY2009 · AI · contact PI
Proteomics Core$272,804
P20 · FY2009 · DA
New Opportunistic Infections in AIDS Microsporidiosis$399,231
R01 · FY2008 · AI · contact PI
Toxoplasma encephalitis in AIDS: Bradyzoite Regulation$347,418
R01 · FY2008 · AI · contact PI
New Opportunistic Infections in AIDS Microsporidiosis$423,571
R01 · FY2007 · AI · contact PI
Toxoplasma encephalitis in AIDS: Bradyzoite Regulation$354,146
R01 · FY2007 · AI · contact PI
A Therapeutic Target for Microsporidiosis$201,483
R21 · FY2007 · AI · contact PI
Second International Workshop on Microsporidia from Vertebrate and Invertebrate H$12,000
R13 · FY2007 · AI · contact PI
New Opportunistic Infections in AIDS Microsporidosis$387,487
R01 · FY2006 · AI · contact PI
Toxoplasma encephalitis in AIDS:Bradyzoite Regulations$363,808
R01 · FY2006 · AI · contact PI
A Therapeutic Target for Microsporidiosis$214,269
R21 · FY2006 · AI · contact PI
New Opportunistic Infections in AIDS Microsporidosis$381,532
R01 · FY2005 · AI
Toxoplasma encephalitis in AIDS:Bradyzoite Regulations$315,138
R01 · FY2005 · AI
New Opportunistic Infections in AIDS Microsporidosis$383,366
R01 · FY2004 · AI
TOXOPLASMA ENCEPHALITIS IN AIDS:BRADYZOITE REGULATION$334,000
R01 · FY2004 · AI
International Congress on Microsporidiosis$10,000
R13 · FY2004 · AI
TOXOPLASMA ENCEPHALITIS IN AIDS:BRADYZOITE REGULATION$334,000
R01 · FY2003 · AI
Microsporidiosis:A Therapeutic Target$250,500
R21 · FY2003 · AI
New Opportunistic Infections in AIDS Microsporidosis$197,821
R01 · FY2003 · AI
NEW OPPORTUNISTIC INFECTIONS IN AIDS--MICROSPORIDIOSIS$377,876
R01 · FY2002 · AI
TOXOPLASMA ENCEPHALITIS IN AIDS:BRADYZOITE REGULATION$334,500
R01 · FY2002 · AI
Microsporidiosis:A Therapeutic Target$243,246
R21 · FY2002 · AI
NEW OPPORTUNISTIC INFECTIONS IN AIDS--MICROSPORIDIOSIS$471,752
R01 · FY2001 · AI
TOXOPLASMA ENCEPHALITIS IN AIDS:BRADYZOITE REGULATION$335,000
R01 · FY2001 · AI
NEW OPPORTUNISTIC INFECTIONS IN AIDS--MICROSPORIDIOSIS$368,004
R01 · FY2000 · AI